Acute Respiratory Infections (ARIs)
12
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Randomized Controlled Trial to Evaluate the Efficacy of Surgical Masks in Preventing Acute Respiratory Infections
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
FebriDx® Pediatric Validation Study
Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (2026-2028)
Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)
FebriDx® Method Comparison Study Protocol
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged ≥50 Years in China
Acute Respiratory Disease as a Fulcrum Point to Quit Smoking: Evaluation of an ED-based Intervention
Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)
Nudging Guideline-concordant Antibiotic Prescribing Using Public Commitments
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)